STOCK TITAN

Edesa Biotech, Inc. (EDSA) Net Income by Year

EDSA

Edesa Biotech, Inc. reported a net loss of $7.2M in fiscal year 2025. This represents a decrease of 16.5% from the prior fiscal year. The table below carries 13 fiscal years, from 2012 to 2025, and the quarters Edesa Biotech, Inc. has filed alongside them.

FY2025 annual
Net Income -$7.2M
YoY -16.5%
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

EDSA Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-K
Net Income-$7.2M-16.5%-$6.2M+26.3%-$8.4M+52.3%-$17.5M-31.5%-$13.3M-109.7%-$6.4M-$1.5M+69.5%-$5.0M-0.1%-$5.0M-76.8%-$2.8M+66.3%-$8.4M+41.8%-$14.5M-162.2%-$5.5M

EDSA Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
Net Income-$5.4M-209.1%-$4.2M-165.2%-$2.2M-39.0%N/A-$1.7M-4.9%-$1.6M+14.6%-$1.6M+3.6%N/A-$1.7M+16.0%-$1.9M+20.3%-$1.7M+28.1%N/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Edesa Biotech, Inc. financials

Frequently Asked Questions

What was Edesa Biotech, Inc.'s net income in fiscal year 2025?

Edesa Biotech, Inc. reported a net loss of $7.2M in fiscal year 2025.

How fast is Edesa Biotech, Inc.'s net income growing?

Edesa Biotech, Inc. (EDSA) net income fell by 16.5% year over year, from -$6.2M to -$7.2M in fiscal year 2025.

How has Edesa Biotech, Inc.'s net income changed over the years?

Across the 13 fiscal years this page covers, Edesa Biotech, Inc. (EDSA) net income went from -$5.5M in fiscal year 2012 to -$7.2M in fiscal year 2025.

Edesa Biotech, Inc. (EDSA) reported -$5.4M in net income in Q3 2026. This represents a decrease of 209.1% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Edesa Biotech, Inc. (EDSA) reported on that line in every period on record.